The effect of intralesional steroid injections on esophageal strictures and the child as whole: A case series.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 13 02 2019
revised: 12 04 2019
accepted: 15 05 2019
pubmed: 15 6 2019
medline: 2 10 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

The most frequent complication after esophageal atresia repair remains anastomotic stricture formation. The initial treatment is endoscopic dilatation. Intralesional steroid injection (ISI) might be an effective adjuvant treatment in case of recurrent strictures. In this series we present our initial experience with this intervention. Data on primary surgery, stricture treatment, postoperative complications, outcome and growth were retrospectively collected from electronic patient records. Findings were analyzed by descriptive statistics and mixed model analysis. Between 2014 and 2017, ISI was performed for severe recurrent anastomotic strictures in six patients (median age at injection 12.4 (2.1-34.7) months) after a median of 6 (2-20) dilatations. In five patients ISI was successful and the stenosis was cleared. No postoperative complications were reported, especially none related to acute adrenal suppression. Comparing the year before with the year after ISI, a significant positive change for weight (r = 0.70, p = 0.003) was calculated versus a negative change for height (r = -0.87, p = 0.003). We found ISI to be an effective adjuvant treatment to recurrent anastomotic stricture dilatation after esophageal atresia repair, without postoperative complications or symptoms of adrenal suppression. It remains important, however, to monitor growth effects. Further evaluation is required in a large prospective study. Treatment study, Level IV (case series).

Sections du résumé

BACKGROUND BACKGROUND
The most frequent complication after esophageal atresia repair remains anastomotic stricture formation. The initial treatment is endoscopic dilatation. Intralesional steroid injection (ISI) might be an effective adjuvant treatment in case of recurrent strictures. In this series we present our initial experience with this intervention.
METHODS METHODS
Data on primary surgery, stricture treatment, postoperative complications, outcome and growth were retrospectively collected from electronic patient records. Findings were analyzed by descriptive statistics and mixed model analysis.
RESULTS RESULTS
Between 2014 and 2017, ISI was performed for severe recurrent anastomotic strictures in six patients (median age at injection 12.4 (2.1-34.7) months) after a median of 6 (2-20) dilatations. In five patients ISI was successful and the stenosis was cleared. No postoperative complications were reported, especially none related to acute adrenal suppression. Comparing the year before with the year after ISI, a significant positive change for weight (r = 0.70, p = 0.003) was calculated versus a negative change for height (r = -0.87, p = 0.003).
CONCLUSIONS CONCLUSIONS
We found ISI to be an effective adjuvant treatment to recurrent anastomotic stricture dilatation after esophageal atresia repair, without postoperative complications or symptoms of adrenal suppression. It remains important, however, to monitor growth effects. Further evaluation is required in a large prospective study.
TYPE OF STUDY METHODS
Treatment study, Level IV (case series).

Identifiants

pubmed: 31196669
pii: S0022-3468(19)30361-6
doi: 10.1016/j.jpedsurg.2019.05.013
pii:
doi:

Substances chimiques

Glucocorticoids 0
Triamcinolone Acetonide F446C597KA

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

646-650

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Chantal A Ten Kate (CA)

Department of Pediatric Surgery and Intensive Care, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands. Electronic address: c.tenkate@erasmusmc.nl.

John Vlot (J)

Department of Pediatric Surgery and Intensive Care, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands. Electronic address: john.vlot@erasmusmc.nl.

Cornelius E J Sloots (CEJ)

Department of Pediatric Surgery and Intensive Care, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands. Electronic address: c.sloots@erasmusmc.nl.

Erica L T van den Akker (ELT)

Department of Pediatric Endocrinology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands. Electronic address: e.l.t.vandenakker@erasmusmc.nl.

Rene M H Wijnen (RMH)

Department of Pediatric Surgery and Intensive Care, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands. Electronic address: r.wijnen@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH